Altre lingue Organogenesis Holdings Inc.

Azioni

ORGO

US68621F1021

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 25/06/2024			Variaz. 5gg	Var. 1 gen.
2,5 ^USD	+1,63%		+1,21%	-38,88%

13/05	ORGANOGENESIS HOLDINGS INC. : per Morgan Stanley il titolo è Neutral	ZM
09/05	Transcript : Organogenesis Holdings Inc., Q1 2024 Earnings Call, May 09, 2024

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference	06/06
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN	14/05
Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	10/05
Organogenesis: Q1 Earnings Snapshot	09/05
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M	09/05
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results	09/05
Organogenesis Holdings Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024	09/05
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis	02/05
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis	02/05
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	16/04
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case	03/04
Organogenesis: Q4 Earnings Snapshot	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M	29/02
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance	29/02
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference	12/02
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024	08/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Organogenesis Holdings Inc.

Azioni

ORGO

US68621F1021

Altre lingue

Filtri